140 related articles for article (PubMed ID: 1874493)
1. Systemic, splanchnic and renal hemodynamic effects of a dopaminergic dose of dopamine in patients with cirrhosis.
Bacq Y; Gaudin C; Hadengue A; Roulot D; Braillon A; Moreau R; Lebrec D
Hepatology; 1991 Sep; 14(3):483-7. PubMed ID: 1874493
[TBL] [Abstract][Full Text] [Related]
2. Selective dopamine DA1 stimulation with fenoldopam in cirrhotic patients with ascites: a systemic, splanchnic and renal hemodynamic study.
Hadengue A; Moreau R; Bacq Y; Gaudin C; Braillon A; Lebrec D
Hepatology; 1991 Jan; 13(1):111-6. PubMed ID: 1671029
[TBL] [Abstract][Full Text] [Related]
3. Effects of propranolol on renal blood flow and renal function in patients with cirrhosis.
Bataille C; Bercoff E; Pariente EA; Valla D; Lebrec D
Gastroenterology; 1984 Jan; 86(1):129-33. PubMed ID: 6357936
[TBL] [Abstract][Full Text] [Related]
4. [Clinical and experimental investigations of the effect of dopamine on haemodynamics and function of kidney and liver (author's transl)].
Peschl L
Wien Klin Wochenschr Suppl; 1978; 86():1-33. PubMed ID: 274863
[TBL] [Abstract][Full Text] [Related]
5. Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: comparison with vasopressin.
Bosch J; Kravetz D; Rodes J
Gastroenterology; 1981 Mar; 80(3):518-25. PubMed ID: 6108897
[TBL] [Abstract][Full Text] [Related]
6. Effect of somatostatin on splanchnic hemodynamics in patients with cirrhosis of the liver and in normal subjects.
Sonnenberg GE; Keller U; Perruchoud A; Burckhardt D; Gyr K
Gastroenterology; 1981 Mar; 80(3):526-32. PubMed ID: 6108898
[TBL] [Abstract][Full Text] [Related]
7. Hemodynamic study during transdermal application of nitroglycerin tape in patients with cirrhosis.
Iwao T; Toyonaga A; Sumino M; Takagi K; Ohkubo K; Inoue R; Tanikawa K
Hepatology; 1991 Jan; 13(1):124-8. PubMed ID: 1899080
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the short-term effects of mepindolol and propranolol on splanchnic and systemic haemodynamics in patients with cirrhosis.
Braillon A; Calès P; Lebrec D
Int J Clin Pharmacol Res; 1985; 5(4):223-8. PubMed ID: 4055165
[TBL] [Abstract][Full Text] [Related]
9. Hemodynamic and sympathetic responses to human atrial natriuretic peptide infusion in patients with cirrhosis.
Brenard R; Moreau R; Pussard E; Champigneulle B; Gaudin C; Hadengue A; Braillon A; Lebrec D
J Hepatol; 1992 Mar; 14(2-3):347-56. PubMed ID: 1386858
[TBL] [Abstract][Full Text] [Related]
10. Effects of bolus injections and continuous infusions of somatostatin and placebo in patients with cirrhosis: a double-blind hemodynamic investigation.
Cirera I; Feu F; Luca A; García-Pagán JC; Fernández M; Escorsell A; Bosch J; Rodés J
Hepatology; 1995 Jul; 22(1):106-11. PubMed ID: 7601400
[TBL] [Abstract][Full Text] [Related]
11. [Relation between plasma catecholamines, the severity of the liver disease and hemodynamics in patients with cirrhosis].
Gaudin C; Braillon A; Moreau R; Roulot D; Bacq Y; Hadengue A; Lebrec D
Gastroenterol Clin Biol; 1989; 13(8-9):701-6. PubMed ID: 2680727
[TBL] [Abstract][Full Text] [Related]
12. Acute systemic and splanchnic haemodynamic effects of L-carnitine in patients with cirrhosis.
Pugliese D; Sabbà C; Ettorre G; Berardi E; Antonica G; Godi L; Palasciano G; Lee SS; Albano O
Drugs Exp Clin Res; 1992; 18(4):147-53. PubMed ID: 1451645
[TBL] [Abstract][Full Text] [Related]
13. [Measurement of portal blood flow in man by a continuous local thermodilution method. III. Effects of dopamine on systemic and portal hemodynamics after hepatectomy].
Kinoshita H; Yamazaki O; Sakai K; Hirohashi K; Kubo S; Iwasa R; Fujio N
Nihon Geka Gakkai Zasshi; 1989 Apr; 90(4):556-65. PubMed ID: 2548075
[TBL] [Abstract][Full Text] [Related]
14. Hemodynamic responses to dopamine infusion at controlled normal and low cardiac output states in the anesthetized dog.
Gooding JM; Karp RB; Appelbaum A; Tracy WG
J Thorac Cardiovasc Surg; 1977 May; 73(5):758-62. PubMed ID: 850435
[TBL] [Abstract][Full Text] [Related]
15. [Effects of glypressin on the splanchnic and systemic circulation in patients with cirrhosis].
Valla D; Lee SS; Moreau R; Hadengue A; Sayegh R; Lebrec D
Gastroenterol Clin Biol; 1985 Dec; 9(12):877-80. PubMed ID: 3830801
[TBL] [Abstract][Full Text] [Related]
16. Effect of oral propranolol administration on azygos, renal and hepatic uptake and output of catecholamines in cirrhosis.
Bendtsen F; Christensen NJ; Sørensen TI; Henriksen JH
Hepatology; 1991 Aug; 14(2):237-43. PubMed ID: 1860681
[TBL] [Abstract][Full Text] [Related]
17. Hemodynamic effects of vasopressin, alone and in combination with nitroprusside, in patients with liver cirrhosis and portal hypertension.
Mols P; Hallemans R; Van Kuyk M; Melot C; Lejeune P; Ham H; Vertongen F; Naeije R
Ann Surg; 1984 Feb; 199(2):176-81. PubMed ID: 6696534
[TBL] [Abstract][Full Text] [Related]
18. The effects of chronic endoscopic variceal sclerotherapy on systemic and splanchnic hemodynamics in patients with cirrhosis.
Ota K; Shijo H; Kokawa H; Kubara K; Kim T; Akiyoshi N; Yokoyama M; Okumura M
Intern Med; 1994 Dec; 33(12):745-51. PubMed ID: 7718954
[TBL] [Abstract][Full Text] [Related]
19. Effect of somatostatin on splanchnic hemodynamics in patients with liver cirrhosis and portal hypertension.
Merkel C; Gatta A; Zuin R; Finucci GF; Nosadini R; Ruol A
Digestion; 1985; 32(2):92-8. PubMed ID: 2864299
[TBL] [Abstract][Full Text] [Related]
20. Effects of alpha-adrenergic stimulation and beta-adrenergic blockade on azygos blood flow and splanchnic haemodynamics in patients with cirrhosis.
Mastai R; Bosch J; Navasa M; Kravetz D; Bruix J; Viola C; Rodés J
J Hepatol; 1987 Feb; 4(1):71-9. PubMed ID: 3033061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
